SCHEMBL20995353

SCHEMBL20995353

Nc1ccc(-c2cn(C(F)(F)C(F)(F)F)nn2)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALOX5 P09917 1/20 0.41
▸ P2RY14 Q15391 1/20 0.40
▸ RAB9A P51151 6/20 0.36
▸ NPC1 O15118 5/20 0.36
▸ KIF11 P52732 1/20 0.36
▸ MEN1 O00255 6/20 0.36
▸ KMT2A Q03164 6/20 0.36
▸ KEAP1 Q14145 1/20 0.36
▸ PTGS2 P35354 3/20 0.35
▸ MAPT P10636 4/20 0.35
▸ ALDH1A1 P00352 4/20 0.35
▸ SMN1; SMN2 Q16637 4/20 0.35
▸ HPGD P15428 3/20 0.35
▸ KDM4E B2RXH2 2/20 0.35
▸ HSD17B10 Q99714 2/20 0.35
▸ GLA P06280 1/20 0.35
▸ ALOX15 P16050 1/20 0.35
▸ TP53 P04637 2/20 0.35
▸ TSHR P16473 1/20 0.34
▸ GFER P55789 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20995349 0.86 P2RY14 (0.41) ALOX5P2RY14RAB9ANPC1KIF11
SCHEMBL20995378 0.84 CYP19A1 (0.46) RAB9ANPC1MEN1KMT2APTGS2
SCHEMBL20995384 0.83 NPC1 (0.44) RAB9ANPC1MEN1KMT2APTGS2
SCHEMBL20995385 0.83 PTGS2 (0.47) P2RY14KIF11PTGS2
SCHEMBL20995373 0.80 HSP90AA1 (0.52) RAB9ANPC1MEN1KMT2APTGS2
SCHEMBL20995351 0.77 CYP19A1 (0.42) RAB9ANPC1PTGS2
SCHEMBL20995347 0.74 FLT3 (0.41) RAB9ANPC1MEN1KMT2APTGS2
SCHEMBL20995370 0.74 MIF (0.50) NPC1MAPTALDH1A1SMN1; SMN2HPGD
SCHEMBL20995369 0.74 CYP19A1 (0.41) RAB9ANPC1PTGS2TP53
SCHEMBL20995389 0.72 CYP19A1 (0.47) RAB9ANPC1MEN1KMT2APTGS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190161452-A1 Process for the preparation of azidoperfluoroalkanes and N-polyfluoroalkyl azides USTAV ORGANICKE CHEMIE A BIOCHEMIE AV CR, V.V.I. (CZ) 2019-05-30 — — US claimed
US-10590091-B2 Process for the preparation of azidoperfluoroalkanes and N-polyfluoroalkyl azides Ustav Organicke Chemie A Biochemie AV CR , v.v.i. (CZ) 2020-03-17 — — US disclosed
US-20190161452-A1 Process for the preparation of azidoperfluoroalkanes and N-polyfluoroalkyl azides USTAV ORGANICKE CHEMIE A BIOCHEMIE AV CR, V.V.I. (CZ) 2019-05-30 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10590091-B2 Process for the preparation of azidoperfluoroalkanes and N-polyfluoroalkyl azides CYP2F1, PRXL2A, CRBN ALOX5 1221/4885P2RY14 248/4885RAB9A 549/4885
US-20190161452-A1 Process for the preparation of azidoperfluoroalkanes and N-polyfluoroalkyl azides CYP2F1, PRXL2A, CRBN ALOX5 1221/4885P2RY14 248/4885RAB9A 549/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback